Evaluating Cathepsin S as a target and a biomarker in cancer
Emerging evidence has implicated cathepsin S with a pathological role within cancer. As a result, there is a need for novel tools to help unravel the role(s) this protease plays in cancer. A number of reversible and selective cathepsin S inhibitor compounds were evaluated in vitro to determine selec...
Main Author: | Wilkinson, Richard David Alan |
---|---|
Published: |
Queen's University Belfast
2016
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.709859 |
Similar Items
-
Cathepsin S as a potential therapeutic target in radioresistant glioblastoma
by: Foster, Robyn
Published: (2017) -
EphA2 is a poor prognostic biomarker and a novel target in colorectal cancer
by: Dasgupta, Sonali
Published: (2016) -
Oesophageal Cancer : strategies to improve outcomes, and identify novel immunological biomarkers and targets
by: Noble, Fergus
Published: (2014) -
The RNA-binding protein LARP1 as potential biomarker and therapeutic target in ovarian cancer
by: Hopkins, Tom
Published: (2014) -
Evaluation of proteomic and transcriptomic biomarker discovery technologies in ovarian cancer
by: Coveney, C. R. E.
Published: (2016)